✦ LIBER ✦

WS3.1 The effect of ivacaftor on the rate of lung function decline in CF patients with a G551D-CFTR mutation

✍ Scribed by Sawicki, G.S.; McKone, E.; Pasta, D.J.; Wagener, J.; Johnson, C.; Konstan, M.W.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

WS1.1 The effect of ivacaftor, a CFTR po

✍ De Boeck, K.; Munck, A.; Walker, S.; Faro, A.; Hiatt, P.; Chan, J.; Gilmartin, G 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 70 KB

WS7.6 Effect of ivacaftor on lung functi

✍ J.C. Davies; H. Sheridan; P.-S. Lee; T. Song; A. Stone; F. Ratjen 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 60 KB

43 Patient-reported outcomes in Phase 3

✍ A.L. Quittner; B. Ramsey; Q. Dong; K. Yen; J.S. Elborn 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 67 KB

WS3.2 The effect of ivacaftor treatment

✍ Altes, T.; Johnson, M.; Higgins, M.; Fidler, M.; Botfield, M.; Mugler III, J.P.; 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 68 KB

53 Lung function, weight, and sweat chlo

✍ Plant, B.J.; Konstan, M.; Aherns, R.; Rodriguez, S.; Munck, A.; Elborn, J.S.; Jo 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 73 KB

WS23.3 ICM is sensitive to detect potent

✍ Graeber, S.Y.; Hug, M.J.; Sommerburg, O.; Mainz, J.G.; Heinzmann, A.; Tümmler, B 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 61 KB